New Key Statistics Module, Z-Score and F-Score
SZSE:300791 Key Ratios
Market Cap ¥ M | 6,606.80 |
Enterprise Value ¥ M | 7,479.27 |
P/E(ttm) | 18.18 |
PE Ratio without NRI | 18.31 |
Forward PE Ratio | 14.72 |
Price/Book | 2.72 |
Price/Sales | 1.36 |
Price/Free Cash Flow | 183.07 |
Price/Owner Earnings | 132.13 |
Payout Ratio % | 0.72 |
Revenue (TTM) ¥ M | 4,156.00 |
EPS (TTM) ¥ | 1.54 |
Beneish M-Score | -2.31 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 8.90 |
y-y EBITDA Growth Rate % | 2.80 |
EV-to-EBIT | 18.53 |
EV-to-EBITDA | 18.53 |
PEG | 2.06 |
Shares Outstanding M | 235.87 |
Net Margin (%) | 8.08 |
Operating Margin % | 11.21 |
Pre-tax Margin (%) | 7.66 |
Quick Ratio | 1.90 |
Current Ratio | 2.61 |
ROA % (ttm) | 6.54 |
ROE % (ttm) | 13.51 |
ROIC % (ttm) | 10.89 |
Dividend Yield % | 3.92 |
Altman Z-Score | 3.15 |
SZSE:300791 Number of Guru Trades
SZSE:300791 Volume of Guru Trades
Gurus Latest Trades with SZSE:300791
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300791 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sirio Pharma Co Ltd Insider Transactions
No Available Data